Irinotecan

Altico Biotech’s Irinotecan Hydrochloride is a topoisomerase I inhibitor used in chemotherapy for metastatic colorectal, lung, and ovarian cancers. Prevents cancer cell replication and growth.

Description

Irinotecan is a chemotherapy agent used in the treatment of various cancers, including colorectal cancer, non-small cell lung cancer, and ovarian cancer. As a potent topoisomerase I inhibitor, Irinotecan interferes with DNA replication in cancer cells, preventing them from dividing and growing. This makes Irinotecan a highly effective treatment option for aggressive cancers that rely on rapid cell division.

The mechanism of action of Irinotecan involves the inhibition of topoisomerase I, an enzyme responsible for unwinding DNA during replication. By preventing the DNA from properly unwinding, Irinotecan induces DNA damage, which ultimately leads to cancer cell death. This mechanism is particularly effective in tumors that are highly proliferative, such as those found in colorectal and lung cancers.

Altico Biotech is a leading API raw material supplier and pharmaceutical raw materials manufacturer, specializing in delivering high-quality ingredients for pharmaceuticals, cosmetics, and health food industries. As a trusted cosmetic ingredients supplier, they provide organic raw materials for cosmetics, including herbal extracts for cosmetics, ensuring natural and sustainable formulations. Their portfolio includes active pharmaceutical ingredients (API), nutraceutical raw materials, and bulk health food raw materials, catering to the growing demand for health and wellness products. Altico Biotech is your reliable partner for innovative and high-grade natural health food ingredients and nutraceutical raw materials supplier solutions.

More Languages ยป